GE HealthCare Technologies (GEHC) Stock Price, News & Analysis

+0.55 (+0.68%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.32 million shs
Average Volume
3.32 million shs
Market Capitalization
$37.37 billion
P/E Ratio
Dividend Yield
Price Target

GE HealthCare Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
15.8% Upside
$94.80 Price Target
Short Interest
2.73% of Float Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.80mentions of GE HealthCare Technologies in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$7.11 M Sold Last Quarter
Proj. Earnings Growth
From $4.27 to $4.76 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.26 out of 5 stars

Medical Sector

142nd out of 922 stocks

X - Ray Apparatus & Tubes Industry

2nd out of 4 stocks

GEHC stock logo

About GE HealthCare Technologies Stock (NASDAQ:GEHC)

GE HealthCare Technologies Inc. is a leading player in the medical industry, specializing in developing and manufacturing advanced healthcare technologies. With a strong commitment to improving patient outcomes and advancing medical science, the company has established itself as a trusted provider of innovative solutions for healthcare professionals worldwide.

The mission of GE HealthCare Technologies Inc. is to revolutionize healthcare through cutting-edge technology and collaboration. By leveraging its expertise in medical imaging, diagnostics, and biopharmaceutical manufacturing, the company aims to enable healthcare providers to deliver more precise diagnoses, personalized treatment options, and better patient care.

Headquartered in Chicago, Illinois, GE HealthCare Technologies Inc. has a global presence, with operations spanning multiple countries. Its products and services cater to various medical specialties, including radiology, cardiology, oncology, neurology, and more. The company's comprehensive portfolio encompasses medical imaging systems, diagnostic tools, pharmaceutical manufacturing equipment, and digital health solutions.

GE HealthCare Technologies Inc. serves a diverse customer base, including hospitals, clinics, research institutions, and pharmaceutical companies. The company has established strategic partnerships with leading healthcare providers and organizations to drive collaborative innovation and address pressing healthcare challenges.

GE HealthCare Technologies Inc. is led by a dynamic management team with extensive experience in the healthcare industry. The company's Chief Executive Officer (CEO) is Peter Arduini, a seasoned executive known for his strategic vision and operational expertise. Under his leadership, GE HealthCare Technologies Inc. has consistently pursued innovation and growth opportunities.

Jan Makela serves as the CEO of Imaging, overseeing the company's imaging solutions portfolio. With a strong background in medical technology and a focus on customer-centric innovation, Makela has played a crucial role in developing cutting-edge imaging technologies.

GE HealthCare Technologies Inc. has demonstrated strong financial performance in recent years, with consistent revenue growth and solid profit margins. The company's annual sales reached an impressive $18.34 billion in 2022, reflecting its position as a key player in the medical technology industry.

GE HealthCare Technologies Inc. has maintained a healthy financial position, with a favorable price-to-earnings ratio, indicating investor confidence in the company's future earnings potential. The forward-looking price-to-earnings-growth ratio of 3 suggests that the company is well-positioned for sustainable long-term growth.

The company's profitability is further highlighted by its impressive price-to-sales ratio, which indicates that investors are willing to pay a premium for GE HealthCare Technologies Inc.'s products and services. The company's strong cash flow position demonstrates the company's ability to generate substantial cash and reinvest in research and development initiatives.

GE HealthCare Technologies Inc. operates within the broader medical technology industry, encompassing various sub-sectors such as medical imaging, diagnostics, and biopharmaceutical manufacturing. This industry is characterized by rapid technological advancements, increasing demand for innovative solutions, and a growing emphasis on personalized patient care.

Competitors in the medical technology sector include established companies such as Siemens Healthineers, Philips Healthcare, Medtronic, and smaller niche players. GE Healthcare Technologies Inc. distinguishes itself through its diverse product portfolio, global presence, and commitment to continuous innovation.

The company's competitive advantage lies in its strong research and development capabilities, technological expertise, and strategic partnerships. These factors enable GE HealthCare Technologies Inc. to introduce cutting-edge solutions, improve patient outcomes and maintain a strong market position.

GE HealthCare Technologies Inc. is well-positioned to seize growth opportunities in the medical technology industry. The company can capitalize on several factors, including advancements in artificial intelligence and machine learning, increased demand for digital health solutions, and the rising prevalence of chronic diseases.

By leveraging its technological expertise, GE HealthCare can continue to develop innovative products and services that address these industry trends. Additionally, expanding into emerging markets, forging strategic partnerships, and pursuing acquisitions can provide avenues for further growth and market expansion.

While GE HealthCare Technologies Inc. has demonstrated resilience and growth potential, it faces risks and challenges inherent to the medical technology industry. Regulatory changes, evolving reimbursement models, and intense competition can impact the company's operations and profitability.

To mitigate these risks, GE HealthCare Technologies Inc. employs robust risk management strategies, including continuous monitoring of regulatory developments, diversification of product offerings, and proactive engagement with healthcare stakeholders. The company's strong research and development capabilities and focus on innovation allow it to adapt to evolving market dynamics and stay ahead of the competition.

GEHC Stock Price History

GEHC Stock News Headlines

GE HealthCare stock falls on Q1 revenue miss
GE HealthCare Stock Tumbles After Earnings Miss
See More Headlines
Receive GEHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/15 Dividend
Last Earnings
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

X - ray apparatus & tubes
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
10 Analysts


Net Income
$1.57 billion
Pretax Margin


Sales & Book Value

Annual Sales
$19.55 billion
Cash Flow
$5.28 per share
Book Value
$16.26 per share


Free Float
Market Cap
$37.37 billion
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Peter J. Arduini (Age 59)
    President, CEO & Director
    Comp: $4.29M
  • Mr. James K. Saccaro (Age 51)
    VP & CFO
    Comp: $1.52M
  • Dr. Taha Kass-Hout M.D. (Age 52)
    M.S., Chief Science & Technology Officer
    Comp: $4.61M
  • Mr. Frank R. Jimenez Esq.Mr. Frank R. Jimenez Esq. (Age 59)
    VP, General Counsel & Corporate Secretary
    Comp: $2.06M
  • Mr. Jan Makela (Age 55)
    President & CEO of Imaging
    Comp: $1.57M
  • Mr. George Andrew Newcomb (Age 57)
    Controller & Chief Accounting Officer
  • Mr. Jahid Khandaker
    Chief Information Officer
  • Ms. Carolynne Borders
    Chief Investor Relations Officer
  • Ms. Rana Strellis
    Chief Corporate Marketing & Communications Officer
  • Mr. Thomas J. Westrick (Age 55)
    President & CEO of Patient Care Solutions

GEHC Stock Analysis - Frequently Asked Questions

Should I buy or sell GE HealthCare Technologies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GEHC shares.
View GEHC analyst ratings
or view top-rated stocks.

What is GE HealthCare Technologies' stock price target for 2024?

10 brokers have issued 12-month target prices for GE HealthCare Technologies' shares. Their GEHC share price targets range from $80.00 to $110.00. On average, they expect the company's stock price to reach $94.80 in the next twelve months. This suggests a possible upside of 15.8% from the stock's current price.
View analysts price targets for GEHC
or view top-rated stocks among Wall Street analysts.

How have GEHC shares performed in 2024?

GE HealthCare Technologies' stock was trading at $77.32 at the beginning of 2024. Since then, GEHC shares have increased by 5.9% and is now trading at $81.86.
View the best growth stocks for 2024 here

When is GE HealthCare Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024.
View our GEHC earnings forecast

How were GE HealthCare Technologies' earnings last quarter?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) issued its earnings results on Tuesday, April, 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. The business earned $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. GE HealthCare Technologies had a trailing twelve-month return on equity of 25.32% and a net margin of 8.05%. The company's revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.85 earnings per share.

How often does GE HealthCare Technologies pay dividends? What is the dividend yield for GE HealthCare Technologies?

GE HealthCare Technologies announced a quarterly dividend on Friday, March 22nd. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share on Wednesday, May 15th. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date is Thursday, April 18th.
Read our dividend analysis for GEHC

Is GE HealthCare Technologies a good dividend stock?

GE HealthCare Technologies (NASDAQ:GEHC) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.15%. The dividend payout ratio is 3.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GEHC will have a dividend payout ratio of 2.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GEHC.

What guidance has GE HealthCare Technologies issued on next quarter's earnings?

GE HealthCare Technologies updated its FY24 earnings guidance on Tuesday, April, 30th. The company provided earnings per share guidance of $4.20-4.35 for the period, compared to the consensus earnings per share estimate of $4.30.

Who are GE HealthCare Technologies' major shareholders?

GE HealthCare Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Capital Research Global Investors (11.83%), Vanguard Group Inc. (10.63%), Price T Rowe Associates Inc. MD (2.18%), Bank of New York Mellon Corp (0.65%), Swiss National Bank (0.27%) and Perpetual Ltd (0.23%). Insiders that own company stock include Frank R Jimenez, H Lawrence Culp Jr, Jan Makela, Kevin Michael O'neill and Roland Rott.
View institutional ownership trends

How do I buy shares of GE HealthCare Technologies?

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GEHC) was last updated on 5/17/2024 by Staff

From Our Partners